Parkinson's Disease Tulip


advertisement
Reply
 
Thread Tools Display Modes
Old 05-03-2007, 08:01 PM #1
Stitcher's Avatar
Stitcher Stitcher is offline
Magnate
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Stitcher Stitcher is offline
Magnate
Stitcher's Avatar
 
Join Date: Aug 2006
Posts: 2,136
15 yr Member
Default Rotigotine As Levodopa Adjunct Is Effective In Advanced Parkinson's Disease

Rotigotine As Levodopa Adjunct Is Effective In Advanced Parkinson's Disease

Main Category: Parkinson's Disease News
Article Date: 03 May 2007 - 14:00 PDT
http://www.medicalnewstoday.com/heal...&nfid=rssfeeds

Transdermal rotigotine (Neupro) up to doses of 8 and 12 mg/day as adjunctive therapy to levodopa significantly decreases "off time" in patients with advanced Parkinson's disease, according to phase III data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN).

Peter A. LeWitt, MD, professor of neurology at Wayne State University in Milwaukee, Wisconsin, reported results in 351 patients with advanced idiopathic Parkinson's disease who had been randomized to placebo or two target doses of rotigotine (up to either 8 mg/24h or 12mg/24h) for up to seven months. Rotigotine is a non-ergolinic dopamine receptor agonist available as a patch for once-daily use.

The trial, known as Prospective Randomized Evaluation of a new Formulation: Efficacy of Rotigotine (PREFER), included a five-week titration phase followed by a 24-week maintenance phase.

The primary efficacy variable was change from baseline in absolute off time.

Compared to baseline, mean daily decreases in off time were 2.7 hours with the 8mg/24h dose and 2.1 hours with the 12mg/24h dose compared to a 0.9 hour decrease with placebo (P<0.001 and 0.003, respectively).

Patients who had longer off times at enrollment tended to benefit most. The study also found that "on" time without dysykinesia after awakening was more than doubled in the two rotigotine groups compared with placebo.

The most common adverse events in the rotigotine groups were application site reactions, somnolence, nausea and vomiting, and dizziness.

While many patients with advanced Parkinson's disease have a surge in symptoms between dosages of their medications, the 24-hour duration of transdermal rotigotine offers the potential for extended anti-parkinsonian control lasting through the night into the morning hours after awakening, Dr. LeWitt said.

Rotigotine is a non-ergolinic dopamine receptor agonist formulated as a path for once-daily usage. The study was sponsored by Schwarz Pharma.
__________________
You're alive. Do something. The directive in life, the moral imperative was so uncomplicated. It could be expressed in single words, not complete sentences. It sounded like this: Look. Listen. Choose. Act. ~~Barbara Hall

I long to accomplish a great and noble tasks, but it is my chief duty to accomplish humble tasks as though they were great and noble. The world is moved along, not only by the mighty shoves of its heroes, but also by the aggregate of the tiny pushes of each honest worker. ~~Helen Keller
Stitcher is offline   Reply With QuoteReply With Quote

advertisement
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Parkinson's: another look. Is Parkinson's disease caused by a bacteria?" rd42 Parkinson's Disease 5 12-13-2011 12:37 PM
The Parkinson's Institute...New studies link the environment to Parkinson's disease Stitcher Parkinson's Disease 0 04-05-2007 04:09 PM
Caffeine Aids Levodopa in Some Parkinson's Patients olsen Parkinson's Disease 3 10-12-2006 12:42 PM
Rotigotine transdermal patch appears safe ZucchiniFlower Parkinson's Disease 0 10-10-2006 02:09 PM
Univ of Pittsburgh named Parkinson Disease Center for Advanced Research Stitcher Parkinson's Disease 0 08-28-2006 08:15 PM


All times are GMT -5. The time now is 06:22 PM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.